ASP-2016

N/A

Report date: 2024/07/03 18:06:03

Base Information

Drug NameASP-2016
Drug Alias NameASP-2016ASP2016
ClassificationCell and gene therapy > Gene therapy > Viral vector-based gene therapy > Adeno-associated virus vector
Mechanisms of ActionFrataxin Gene transference
TargetsFrataxin, mitochondrial
Therapy Area/IndicationsCardiomyopathiesFriedreich Ataxia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesAstellas Gene Therapies Inc
China Registration ClassN/A

Develop Information

Active CompaniesAstellas Pharma Inc
Inactive CompaniesAstellas Gene Therapies Inc
Active IndicationsCardiomyopathiesFriedreich Ataxia
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A